US Stock MarketDetailed Quotes

SYGGF SYNAIRGEN

Watchlist
  • 0.060000
  • -0.001000-1.64%
Close Mar 28 16:00 ET
12.08MMarket Cap-952P/E (TTM)

About SYNAIRGEN Company

Synairgen Plc is a holding company, which engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease, and severe viral infections. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.

Company Profile

SymbolSYGGF
Company NameSYNAIRGEN
Founded2004
CEOMr. Richard James Marsden
MarketPink Market
Employees30
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressMailpoint 810,Southampton General Hospital,Tremona Road
CitySouthampton
ProvinceLondon & South East
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeSO16 6YD
Phone44-23-8051-2800

Company Executives

  • Name
  • Position
  • Salary
  • Richard James Marsden
  • Executive Director,Chief Executive Officer
  • 328.00K
  • Dr. Phillip David Monk
  • Executive Director,Chief Scientific Officer
  • 240.00K
  • Joseph Colliver
  • Executive Director,Chief Financial Officer
  • --
  • Simon James Blouet Shaw
  • Non-Executive Director,Chairman
  • 84.00K
  • Dr. David Bruce Campbell
  • Non-Executive Director
  • 44.00K
  • Professor Stephen Townley Holgate, CBE
  • Non-Executive Director
  • 44.00K
  • Dr. Felicity Jane Gabbay
  • Non-Executive Director
  • 11.00K
  • Mrs. Amanda Dawn Radford
  • Non-Executive Director
  • 4.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg